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Abstract: Although rare, drug testing in 
schools continues to be practised in some 
European countries. In many cases, drug 
testing is intended to act as a deterrent 
to substance use. Nevertheless, studies 
conducted in the United States show that the 
drug testing of students can have iatrogenic 
effects, sometimes being associated with an 
increase in illicit drug use or an increase in the 
risks associated with substance use.
To evaluate the effectiveness of random 
testing in schools, we conducted a systematic 
review of seven studies that met certain 
inclusion criteria. These studies were all 
conducted in the United States among 
college students between 13 and 19 years of 
age and in one case among athletes. Although 
different with regard to study design and the 
type of testing offered, all of the studies show 
that testing has little or no effect on drug use. 
In addition, the invasiveness of the testing 
procedure and limitations to the information 
derived from drug testing affect its utility as a 
prevention approach. In light of this, experts 
have called for further evidence-based 
studies to help guide best practice for drug 
prevention interventions with adolescents.
Content:  Background (p. 2) I Methods (p. 3) I Results (p. 3) I Conclusions (p. 6) I 
References (p. 13) I Appendix (p. 15 ) I Acknowledgements (p. 17) 
 
 Keywords   drug testing   
 school   students   early detection  
1/17
Recommended citation: European Monitoring Centre  
for Drugs and Drug Addiction (2017), Drug testing in schools, 
EMCDDA Papers, Publications Office of the European Union, 
Luxembourg.
EMCDDA PAPERS I Drug testing in schools
2 / 17
I Background 
A wide range of prevention interventions are implemented 
in school settings in Europe, and it is recommended that the 
selection of appropriate approaches is based on the best 
available scientific evidence. Some particular concerns exist 
about the use of prevention approaches based on deterrence, 
such as testing pupils for drugs, which continues to be used in 
a limited number of European countries despite the fact that 
the empirical evidence as to whether or not the drug testing of 
pupils does in fact affect young people’s drug use behaviour 
has not been systematically scrutinised. This paper explores 
the use of random drug testing in schools, reviews the research 
to date and looks at the implications for the future use of this 
intervention type.
For decades, drug testing has been carried out for substance-
use screening and treatment purposes in military, workplace, 
clinical and criminal justice settings. However, testing pupils 
for drugs as a screening method is rare, at least in Europe. 
According to expert opinions from EU Member States and 
Norway, reported to the EMCDDA in 2016, it is not carried 
out at all, or is even forbidden, in 19 countries. Another 10 (1) 
countries reported that this intervention is carried out, but 
only rarely. In these countries, testing pupils is legally possible, 
but not recommended. In some instances, its use is limited to 
individual cases when it is deemed necessary and reasonable 
(Czech Republic, Finland), and, in some cases, the young 
person’s consent and the consent of their parent or guardian 
are necessary (Ireland, Slovakia Sweden). In Slovakian 
vocational schools, drug testing can be carried out to safeguard 
workplace safety.
In other parts of the world, drug testing in schools is more 
common. In the United States, since the late 1980s, large-
scale drug and alcohol testing (DAT) has been carried out in 
many segments of the US civilian workplace. Since 2003, the 
US Department of Education’s Office of Safe and Drug-Free 
Schools (OSDFS) has operated a grant programme to support 
mandatory-random student drug testing (MRSDT) programmes 
in schools. Under MRSDT programmes, students and their 
parents sign consent forms agreeing to the students’ random 
drug testing as a condition of participation in athletics and 
other school-sponsored competitive extracurricular activities 
(Goldberg et al., 2003; James-Burdumy et al., 2012). In Russia, 
in 2013, a new law was introduced instigating drug testing 
for school students. The testing is held in two stages. During 
the first, socio-psychological, stage, students complete a 
questionnaire. The second stage consists of medical tests and 
examinations of students to identify whether or not there are 
any traces of narcotic substances. The test is conducted on a 
voluntary basis (RT.com, 2013).
(1) Belgium, Croatia, Czech Republic, Hungary, Ireland, Italy, Netherlands, Norway, 
Sweden, United Kingdom.
School-based random student drug testing (RSDT), in 
which, using a variety of randomisation procedures, students 
are assigned for testing or not, is a controversial drug-use 
prevention tool. In many countries, this has been an issue of 
public or political debate. The consent of students and their 
parents has been required in all cases. Most psychoactive 
substances commonly used by teenagers can be detected 
in urine. Inhalants, which typically undergo rapid respiratory 
elimination, are an important exception.
Proponents argue that school-based drug testing reduces 
student substance use by providing students with a reason to 
avoid drug use, that is, the potential negative consequences 
associated with a positive test result, and that it also identifies 
adolescents with substance use disorders, who can then be 
referred for treatment.
Opponents of drug testing argue that it is not appropriate 
from a human rights perspective and also that it is not an 
effective method of prevention (DuPont et al., 2013). The ethical 
considerations voiced against drug testing include the fact 
that that it is seen to undermine children’s rights. In addition, 
the concern was put forward that testing compromises trust 
and can interfere with confidence between schools and 
students. Other concerns regarding school-based drug testing 
include the potential for breaches of privacy (e.g. when a 
student’s prescribed medications are identified on a drug 
test); detrimental consequences, such as the suspension or 
expulsion of students who have positive drug test results; 
increased school dropout or truancy among students who 
fear that they would fail a drug test; and an increased use of 
substances not easily detectable in a drug screen (Levy and 
Schizer, 2015). Student organisations have protested against 
drug testing in Lithuania, Austria and Finland, and student 
support staff, e.g. school doctors in Belgium and youth solicitors 
in Austria, have also objected to its use.
I Why this review?
Although any reduction in student drug use is beneficial, it is 
unclear whether or not school-based drug testing is effective, 
and whether or not it is a good use of limited school resources. 
To date, there is no systematic review that summarises 
empirical evidence to support or refute the efficacy of RSDT in 
schools.
I Objectives
To review and summarise the existing evidence on the 
effectiveness of RSDT programmes in preventing alcohol and 
drug misuse in young adults.
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I Methods 
We searched and reviewed all the studies available with the 
inclusion criteria described below.
I Types of studies
Randomised controlled trials (RCTs) (individual or cluster 
design) and controlled prospective studies (CPSs) reporting 
the evaluation of an RSDT programme versus a control 
condition (no intervention or other preventive intervention to 
prevent substance use among young people) were included. 
The results from the RCTs and the CPSs are summarised 
separately.
I Types of participants 
Students (13–19 years old).
I Types of interventions
Experimental intervention: RSTD.
Control intervention: no intervention; any other preventive 
intervention.
I Types of outcome measures
Primary outcome
1. A reduction in the incidence and prevalence of alcohol and 
other drug use among young people.
Secondary outcomes
1. Intention to use substances.
2. Perceived consequences of substance use.
3. Number of reported disciplinary incidents in schools.
I Search methods for the identification of studies
Electronic searches: all searches included non-English 
language literature.
We searched the following databases:
 ■ Cochrane Drugs and Alcohol Group’s Specialised Register 
of Trials (18 October 2015);
 ■ The Cochrane Central Register of Controlled Trials 
(CENTRAL, issue 10, 2015);
 ■ MEDLINE (PubMed) (January 1966 to February 2017);
 ■ EMBASE (embase.com) (January 1974 to 18 October 
2015);
 ■ ERIC (eric.ed.gov) (January 1988 to 18 October 2015); 
 ■ Web of Science (Thomson Reuters) (January 1995 to 18 
October 2015). 
 ■ Details of the searches are listed in the Appendix.
We also searched for ongoing clinical trials and unpublished 
trials via internet searches on the following sites:
 ■ ClinicalTrials.gov (www.clinicaltrials.gov);
 ■ World Health Organization (WHO) International Clinical 
Trials Registry Platform (ICTRP) (apps.who.int/trialsearch/).
I Data collection and analysis
Selection of studies
Two authors independently screened the titles and abstracts 
of the studies obtained using this search strategy. Each 
potentially relevant study identified in the search was 
obtained as the full-text version and assessed for inclusion 
independently by the two authors.
Data extraction and management
Two authors extracted data independently. Any disagreement 
was discussed and solved by consensus.
I Results 
The search retrieved 921 records and after removing 
duplicates, 700 were considered for inclusion. Of these, 684 
were excluded on the basis of the title and abstract, and 16 
titles were retrieved as full-text versions for closer inspection. 
Of these, nine papers were excluded and seven were 
included. The process of study identification and the results 
are outlined as a flow diagram in Figure 1, in accordance 
with the PRISMA (Preferred Reporting Items for Systematic 
Reviews and Meta-analyses) statement (Moher et al., 2009).
I Characteristics of excluded studies
Nine references were excluded after reading the full text; 
the reasons for exclusion are described in detail in Table A1 
‘Characteristics of the excluded studies’ in the Appendix.
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Barrington, 2007 and 2008
Both Barrington references relate to a quasi-experimental 
study evaluating the effect of voluntary, randomised student 
drug testing (VRSDT) programmes on 1 048 students (in 
grades 6–12, aged 11–17) from two rural, low-income, public 
secondary school districts: 245 from the intervention district 
and 803 from the comparison district.
The results show that there was no statistically significant 
evidence to suggest that the VRSDT intervention had an 
effect on alcohol, tobacco and illicit drug use. The authors 
concluded that, despite the interest and the increased federal 
funding for such testing, there is very little empirical evidence 
to suggest that VRSDT is effective at reducing illicit drug use 
among school students.
Goldberg et al., 2003
SATURN (Student Athlete Testing Using Random Notification) 
is a prospective randomised study including two high 
schools, one with mandatory drug testing with consent before 
sports’ participation and one, the control school, without drug 
testing. Students from both schools were assessed during the 
1999–2000 school year. Athletes and non-athletes in each 
school completed confidential or anonymous questionnaires 
developed for this study, respectively, at the beginning and 
end of the school year. The results show that the past 30-day 
index of illicit drug and athletic-enhancing substance use was 
lower (p < 0.05) among drug tested athletes at follow-up, with 
no statistically significant difference in alcohol use. However, 
most drug-use risk factors, including norms of use, belief in 
lower risk of harm from drugs and poorer attitudes towards 
the school, were higher among the athletes in the drug 
testing school (p < 0.05) than among athletes in the control 
school. Furthermore, although there was a reduction in the 
illicit drug use index among non-athletes at the drug testing 
school at the end of the school year, it was not statistically 
significant (p < 0.10).
Goldberg et al., 2007
A second SATURN prospective randomised controlled study 

























I Characteristics of included studies
Seven papers satisfied the criteria for inclusion: three 
prospective randomised studies (Goldberg et al., 2003, 
2007; James-Burdumy et al., 2012), two quasi-experimental 
studies (Barrington, 2007, 2008); one descriptive analyses 
(Terry-McElrath et al., 2013); and one report (Yamaguchi et 
al., 2003).
All the papers refer to studies conducted in the United States. 
The RCTs are of good quality, based on the criteria developed 
by the Cochrane Collaboration for the assessment of the risk 
of bias in RCTs (Higgins and Green, 2011). It was impossible 
to assess the methodological quality of the remaining 
studies, on account of the types of study design.
I Summary of the main results
The major limitation of the present analysis was the variation 
in the study designs and measures, which made it difficult to 
conduct a meta-analysis of primary studies. Heterogeneity in 
the measurement of outcomes and variations in the quality of 
reporting, for instance some studies included only statistical 
analysis and p-values without an indication of the absolute 
numbers of participants, prevented pooled estimates. The 
conclusions of this paper are therefore based on a narrative 
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high schools with a DAT policy (intervention schools) and 
six high schools with a deferred policy (control schools). 
The students were assessed by voluntary, confidential 
questionnaires. Surveys were administered over five separate 
periods: during the beginning (autumn) and the end (spring) 
of the 2000–2001 and 2001–2002 school years, and during 
the autumn of the 2002–2003 school year. Student-athletes 
from intervention and control schools did not differ in past 
one-month use of illicit drugs or a combination of drugs 
and alcohol by any of the four follow-up periods. At the end 
of the initial school year and after two full school years, 
student-athletes at intervention schools reported less drug 
use during the past year (p < 0.01) than student-athletes at 
the control schools. With regard to the combination of past-
year drug and alcohol use, student-athletes at intervention 
schools reported less use at the second and third follow-up 
assessments (p < 0.05) than student-athletes at control 
schools.
James-Burdumy et al., 2012
This study consisted of a cluster RCT and included 36 high 
schools and 10 980 students in grades 9–12. Half of the 
schools were randomly assigned to a treatment group that 
was permitted to implement MRSDT immediately and the 
remaining half were assigned to a control group that delayed 
MRSDT until after follow-up data collection one year later, 
in spring 2008. Students subject to MRSDT reported less 
substance use than comparable students in high schools 
without MRSDT. In particular, participants in treatment 
schools were significantly less likely than comparable 
students in  control schools, without MRSDT, to report any 
past 30-day use of substances covered by their district’s 
MRSDT policy (effect size = –0.21). Rates of self-reported 
substance use were also lower among participants in 
treatment schools than among those in control schools 
on the other five substance use measures, although these 
differences were not statistically significant after accounting 
for multiple hypotheses testing. Past 30-day marijuana use 
frequency was assessed on a 7-point scale.
Terry-McElrath et al., 2013
This paper reported on a descriptive analysis using 
questionnaire data from the Monitoring the Future study, 
collected from 1998 to 2011. Students participating in 
the survey consisted of those in grades 8, 10 and 12 
who attended a public or private school from a nationally 
representative sample. Students were asked about past 
30-day frequency of marijuana use and about their use of 
lysergic acid diethylamide (LSD), other psychedelics, cocaine, 
heroin, amphetamines and tranquilisers. For those in 12th 
grade, two additional substances were included: sedatives/
barbiturates and narcotics other than heroin. A mean was 
taken from these items to create a scale of the frequency of 
use of illicit drugs other than marijuana (OTM).
The frequency of marijuana use in middle school student-
athletes was significantly lower in schools with either any 
athlete student drug testing (SDT) or random athlete SDT. 
Among middle school students participating in non-athletic 
extracurricular activities, random testing aimed at that group 
was associated with a significantly higher prevalence of OTM 
drug use.
Marijuana use frequency and prevalence were significantly 
lower among high school student-athletes in schools with 
either any athlete SDT or random athlete SDT than among 
students in schools with no SDT. Among high school students 
participating in non-athletic extracurricular activities, 
marijuana use prevalence reduction was significantly 
associated with any SDT and any random SDT aimed at this 
group. In contrast, OTM drug use frequency was significantly 
associated with any SDT testing targeting such students.
In addition, among high school students attending schools 
with either drug testing for a particular cause (for-cause SDT) 
or any random SDT, both perceived risk and the number of 
students reporting that they disapprove of using marijuana 
regularly were higher with higher levels of for-cause and 
random SDT.
Yamaguchi et al., 2003
This report summarised the findings from two sets of 
analyses of data from the Monitoring the Future study 
conducted to examine the association between drug testing 
in schools and reported drug use by students in the 8th, 
10th and 12th grades. For marijuana use among students 
in grades 8, 10 and 12, drug testing (of any kind) was not 
a significant predictor of student marijuana use in the 12 
months prior to the survey, and neither was drug testing 
for cause or suspicion. These results were consistent for all 
samples, even after controlling for student demographic 
characteristics. Similar to results for marijuana use, drug 
testing of any kind and drug testing for cause and suspicion 
were not significant predictors of the use of other illicit drugs 
among students in grades 8, 10 and 12. Even after controlling 
for student demographic characteristics, drug testing was 
not a significant predictor of other illicit drug use in any of the 
samples.
Table 1 gives an overview of the papers and reports identified 
for this review, describing the objectives, results and 
conclusions of the authors in more detail.
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I Conclusions
The findings from this review indicate that there is little 
scientific evidence to support the use of randomised drug 
testing for reducing drug use among those tested and among 
their school peers.
Based on the inconsistent results of the reviewed studies, it 
is not clear whether or not drug testing in schools has any 
significant impact on students’ self-reported rates of illicit 
drug use. Among the 8th-, 10th- and 12th-grade students 
surveyed, school drug testing was not associated with either 
the prevalence or the frequency of marijuana use or of other 
illicit drug use. Only one study showed that moderately lower 
marijuana use was associated with any random testing of the 
general high school student population and among students 
specifically subject to testing (athletes or participants in non-
athletic extracurricular activities). However, SDT was generally 
associated with increased use of illicit drugs OTM and the 
study’s authors recommended that, until further research can 
clarify the conflicting outcomes, schools should approach 
drug testing with caution. A further limitation of these results 
is that all the reviewed studies were conducted in the United 
States, and the results are therefore not directly transferable to 
a European context.
The invasiveness of the procedure and limitations of the 
information derived from drug testing also affect its utility 
as a prevention approach. Drug testing is only a tool used to 
identify who has been using drugs during the period prior to 
testing. Where it is used, the most important issue to consider 
is the procedures used to follow up on the results and 
effectively help, not punish, students who test positive for drug 
use. The research literature indicates that positive tests need 
to be followed up by further assessments and by providing 
students with or referring them to counselling, for treatment or 
to other healthcare and psychosocial services.
In conclusion, there is a clear need for further evidence-
based studies to guide best practices to support successful 
prevention interventions with adolescents. Microtrials and 
RCTs need to be conducted to explore the evidence for a wide 
range of prevention interventions, in varied school populations 
and in cross-national studies using common research designs 
and measures.
TABLE 1
Overview of included reports
Author (year) Barrington (2007 and 2008)
Objective To measure students’ drug use prior to and after drug testing programme implementation. 
Study design Quasi-experimental data from a survey administered in 2005, 2006 and 2007. 
Participants 1 048 students (in grades 6–12) participating in US school-sponsored extracurricular activities in two rural, low-income, public 
secondary school districts; 245 (23.4 %) students from the intervention district and 803 (76.6 %) students from the comparison 
district.
Outcomes Alcohol, tobacco and illicit drug use.
Results Alcohol use: results showed a distinct decreasing trend in the comparison district and a slight increasing trend in the intervention 
district. However, the interaction between year and district was not statistically significant (p = 0.16) and, thus, the null hypothesis 
was not rejected and it was concluded that there was no evidence to suggest that the change in alcohol use over the three-year 
period was different for the two districts.
Tobacco use: results showed little evidence that tobacco use over time was different for the two districts. The interaction between 
year and district was not statistically significant (p = 0.79) and, thus, the null hypothesis was not rejected and it was concluded 
that there was no evidence to suggest that the change in tobacco use over the three-year period was different for the two 
districts.
Illicit drug use (marijuana and cocaine): results showed a distinct decreasing trend in the comparison district and a less apparent 
downwards trend in the intervention district. However, the interaction between year and district was not statistically significant 
(p = 0.20) and, thus, the null hypothesis was not rejected and it was concluded that there was no evidence to suggest that the 
change in illicit drug use over the three-year period was different for the two districts.
Conclusions of the 
authors
The quantitative findings of this quasi-experimental study revealed that VRSDT had no significant impact on students’ self-
reported rates of illicit drug use.
Author (year) Goldberg et al. (2003) 
Objective To assess the deterrent effect of mandatory, random drug testing among high school athletes in a controlled setting.
Study design Longitudinal survey SATURN: data from a survey. Two US high schools — one with mandatory drug testing with consent before 
sports’ participation, and a control school without drug testing — were assessed during the 1999–2000 school year. 
Participants 276 adolescent athletes (135 experimental and 141 control) were enrolled in the study and assessed at baseline. Of student 
athletes assessed pre-season, 57 % (n = 159; 97 experimental and 62 control; p = 0.05) were assessed at the end of the school 
year.  
Furthermore, 507 non-athletes were assessed by questionnaire; 338 at baseline (170 control and 168 experimental) and 226 at 
the end of the school year (117 control and 109 experimental). 
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TABLE 1 (continued)
Outcomes Substance use: alcohol, illicit drugs, ergogenic substances and ‘athletic’ supplements, assessed at baseline and at the end of the 
school year. 
The illicit drug index included measures of marijuana, cocaine in any form, amphetamines/methamphetamines, narcotics, 
phencyclidine (PCP) and inhalants. The ergogenic substance index included athletic-enhancing drugs comprising anabolic 
androgenic steroids, amphetamines and methamphetamines, plus pseudoephedrine, other over-the-counter stimulants, 
anabolic steroid precursors, androstenedione and creatine. An additional index included the ergogenic drugs without athletic 
supplements.
Results Athletes drug use proportions and attitude construct means (and standard deviations) for the experimental and control groups 
before and after the drug testing intervention.











New lifetime drug use (use at the posttest by students who had not used at the pretest)
Any drugs 0.000 0.364 (0.481) 0.000 0.400 (0.490) 0.546 (1.071)
Alcohol 0.000 0.313 (0.464) 0.000 0.478 (0.500) 0.671 (0.703)
Tobacco 0.000 0.167 (0.373) 0.000 0.233 (0.423) 0.395 (0.659)
Illicit drugs 0.000 0.128 (0.334) 0.000 0.327 (0.469) 1.029 (0.579)**
Ergogenic drugs 0.000 0.096 (0.295) 0.000 0.107 (0.309) 0.195 (0.599)
Ergogenic substances 0.000 0.118 (0.323) 0.000 0.129 (0.335) 0.219 (0.653)
Past 30-day drug use
Any drugs 0.339 (0.473) 0.417 (0.493) 0.333 (0.471) 0.309 (0.462) –0.431 (0.379)
Alcohol 0.183 (0.387) 0.183 (0.387) 0.215 (0.411) 0.247 (0.431) 0.348 (0.427)
Tobacco (smoked or chewed) 0.373 (0.484) 0.386 (0.487) 0.405 (6.491) 0.306 (0.461) –0.144 (0.098)
Illicit drugs 0.065 (0.247) 0.194 (0.395) 0.074 (0.262) 0.053 (0.224) –1.531 (0.600)*
Ergogenic drugs 0.049 (0.216) 0.113 (0.317) 0.053 (0.224) 0.032 (0.176) –1.264 (0.806)
Ergogenic substances 0.150 (0.357) 0.226 (0.421) 0.098 (0.297) 0.053 (0.224) –1.799 (0.677)*
Attitudes and beliefs
Attitudes toward school 5.062 (1.315) 4.855 (1.393) 4.737 (1.306) 3.842 (1.328) –0.878 (0.194)*
Negative consequences of drug use 5.915 (1.072) 5.877 (1.003) 5.211 (1.370) 5.179 (1.142) –0.462 (0.171)*
Positive consequences of drug use 2.165 (1.262) 2.391 (1.175) 2.616 (1.422) 2.787 (1.177) 0.285 (0.179)
Descriptive norms about peers 4.373 (1.734) 4.207 (1.607) 5.763 (2.171) 5.826 (1.961) 1.146 (0.281)*
Injunctive norms about peers 2.851 (1.205) 3.023 (1.280) 3.422 (1.248) 3.628 (1.212) 0.326 (0.175)**
Injunctive norms about authority figures 1.525 (0.940) 1.540 (0.901) 2.116 (1.399) 2.179 (1.287) 0.570 (0.182)*
Risky behavior 2.676 (1.297) 2.569 (1.333) 3.146 (1.397) 3.170 (1.168) 0.411 (0.179)*
Fear of consequences 4.626 (0.997) 4.552 (1.053) 4.178 (1.079) 4.087 (1.022) –0.209 (0.163)
Attitudes toward drug testing 5.003 (1.585) 4.613 (1.626) 4.400 (1.662) 4.040 (1.645) –0.312 (0.231)
Beliefs about testing efficacy 4.847 (1.081) 4.863 (0.942) 4.416 (1.180) 4.274 (1.108) –0.480 (0.169)*
Beliefs regarding testing benefits 4.868 (1.210) 4.633 (1.112) 4.412 (1.396) 3.983 (1.206) –0.414 (0.162)*
Likelihood of being tested 4.557 (2.179) 4.642 (1.947) 5.700 (1.897) 4.622 (1.697) –0.539 (0.353)
Psychological reactance 1.994 (0.968) 2.335 (1.038) 2.663 (1.224) 2.883 (1.195) 0.294 (0.163)**
Testing as a reason not to use 4.610 (1.301) 4.543 (1.249) 4.704 (1.276) 4.299 (1.179) –0.279 (0.179)
* p < 0.05; ** p < 0.10. 
Note. The “illicit drug” index includes marijuana, cocaine, amphetamines, narcotics, sniffing glue or paint, and phencyclidine 
(PCP). The “ergogenic drug” index includes anabolic steroids, androstenedione, and amphetamines. The “ergogenic substance” 
index includes anabolic steroids, androstenedione, amphetamines, creatine, and pseudoephedrine. The “any drugs” index 
includes all listed drugs. Logistic regression was used for the analysis of the drug use measures.
EMCDDA PAPERS I Drug testing in schools
8 / 17
TABLE 1 (continued)
Non-athletes drug use proportions and attitude construct means (and standard deviations) for the experimental and control 
groups before and after the drug testing intervention.
Conclusions of the 
authors
Random drug testing may have reduced substance use among athletes. However, worsening of risk factors and small sample 
size suggests caution to this drug prevention approach should be exercised. A larger, long-term study to confirm these findings is 
necessary.
Author (year) Goldberg et al. (2007)
Objective To assess the effects of random DAT among high school athletes.
Study design Prospective randomised controlled study of a single cohort among five intervention high schools with a DAT policy and six 
schools with a deferred policy, serially assessed by voluntary, confidential questionnaires. Surveys were administered over five 
separate periods: during the beginning/autumn and the end/spring of the 2000–2001 and 2001–2002 school years, and during 
the autumn of the 2002–2003 school year.
Participants DAT: five schools (653 student-athletes); control: six schools (743 student-athletes).
Outcomes Illicit drug use (alcohol, marijuana, amphetamines, narcotics, sniffing glue, anabolic steroids) with and without alcohol use 
assessed at the beginning and end of each school year for the past month and prior year.











Lifetime drug use 
Any drugsa 0.809 (0.393) 0.795 (0.404) 0.822 (0.383) 0.835 (0.371) 0.030 (0.121)
Alcohol 0.757 (0.429) 0.754 (0.431) 0.770 (0.421) 0.787 (0.409) 0.009 (0.112)
Tobacco (smoked or chewed) 0.667 (0.471) 0.672 (0.469) 0.706 (0.456) 0.679 (0.467) –0.051 (0.100)
Illicit drugs 0.545 (0.498) 0.603 (0.489) 0.609 (0.488) 0.578 (0.494) –0.115 (0.095)
Ergogenic drugs 0.230 (0.421) 0.231 (0.421) 0.202 (0.401) 0.174 (0.379) –0.048 (0.113)
Ergogenic substancesa 0.241 (0.428) 0.284 (0.451) 0.221 (0.415) 0.222 (0.416) –0.060 (0.107)
Past 30-day drug use
Any drugsa 0.482 (0.500) 0.509 (0.500) 0.553 (0.497) 0.556 (0.497) –0.041 (0.095)
Alcohol 0.268 (0.443) 0.366 (0.482) 0.404 (0.491) 0.417 (0.493) –0.118 (0.099)
Tobacco (smoked or chewed) 0.373 (0.484) 0.386 (0.487) 0.405 (0.491) 0.306 (0.461) –0.144 (0.098)
Illicit drugs 0.239 (0.426) 0.322 (0.467) 0.327 (0.469) 0.266 (0.442) –0.183 (0.103)**
Ergogenic drugs 0.045 (0.207) 0.095 (0.293) 0.075 (0.263) 0.064 (0.245) –0.255 (0.186)
Ergogenic substancesa 0.054 (0.226) 0.112 (0.315) 0.092 (0.289) 0.083 (0.276) –0.241 (0.170)
Attitudes and beliefs
Attitudes toward school 4.073 (1.718) 3.655 (1.626) 4.013 (1.559) 3.801 (1.675) 0.061 (0.074)
Descriptive norms about peers 4.693 (2.552) 5.193 (2.217) 4.983 (2.346) 5.549 (2.205) 0.020 (0.108)
Injunctive norms about peersb 3.900 (1.741) 3.744 (1.616) 4.022 (1.668) 4.035 (1.659) 0.022 (0.076)
Risky behaviorb 3.591 (2.190) 3.607 (2.013) 3.852 (2.050) 3.963 (2.087) 0.012 (0.095)
Attitudes toward drug testing 3.887 (1.707) 3.643 (1.713) 3.581 (1.889) 3.502 (1.788) 0.049 (0.080)
Beliefs about testing efficacy 3.650 (1.364) 3.560 (1.425) 3.578 (1.346) 3.333 (1.394) –0.036 (0.063)
Psychological reactanceb 3.468 (1.698) 3.295 (1.767) 3.731 (1.976) 3.601 (1.804) –0.003 (0.084)
Testing as a reason not to useb 3.557 (1.501) 3.423 (1.549) 3.534 (1.462) 3.381 (1.421) 0.004 (0.068)
* p < 0.05; ** p < 0.10.  
Note. The “illicit drug”. 
a Index does not include pseudoehpedrine that is part of the athlete index. 
b Construct does not have all the times that are part of the athlete constructs.
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TABLE 1 (continued)
Results Mean drug use index score by condition across time
Conclusions of the 
authors
No DAT deterrent effects were evident for past-month use during any of four follow-up periods. Prior-year drug use was reduced 
in two of four follow-up self-reports, and a combination of drug and alcohol use was reduced at two assessments as well. Overall, 
drug testing was accompanied by an increase in some risk factors for future substance use. More research is needed before DAT 
is considered an effective deterrent for school-based athletes. 
Author (year) James-Burdumy et al. (2012)
Objective To test the effectiveness of MRSDT in reducing substance use among high school students.
Study design Cluster RCT.
Participants 36 high schools and 10 980 students in grades 9–12. Half the schools were randomly assigned to a treatment group that was 
permitted to implement MRSDT immediately, and the remaining half were assigned to a control group that delayed MRSDT until 
after follow-up data collection was completed one year later, in spring 2008. Data from self-administered student questionnaires 
were used to compare rates of substance use in treatment and control schools at follow-up.
Outcomes Substance use, intention to use substances, perceived consequences of substance use, participation in covered activities, school 
connectedness.
Results Impacts on substance use for covered-activity participants
Substance use Time 1 Time 2 Time 3 Time 4 Time 5
Past month illicit drug use
Deferred 0.207 0.237 0.168 0.265 0.261
DAT 0.177 0.237 0.177 0.276 0.165
Past month illicit drug and alcohol use
Deferred 0.516 0.663 0.562 0.649 0.614
DAT .558 .640 .572 .836 0.627
Past year illicit drug useb
Deferred 0.358 0.475 0.410 0.453 0.431
DAT 0.454 0.417** 0.447 0.457 0.305**
Past year illicit drug and alcohol use
Deferred 0.910 1.092 1.092 1.068 1.033
DAT 0.980 0.977* 0.955* 1.055 0.917
a Index scores range from 0–3, where 0 = no use and 3 = heavy use.
b Effect of treatment across time was significant, F(4,36) = 4.22,  p < .01.
* p < .05 for post hoc contrast test of treatment from Time 1 to this time.






Percentage of students that reported using the following in the past 6 months
Any substance 52.61 49.72 2.90 .835 .07
Any substance except alcohol and tobacco 22.11 21.89 .23 1.000 .01
Any substance tested by the district’s MRSDT program 33.43 32.55 .89 .984 .02
Percentage of students that reported using the following in the past 30 days
Any substance 36.04 35.70 .34 1.000 .01
Any substance except alcohol and tobacco 15.03 16.52 –1.49 .910 –.07
Any substance tested by the district’s MRSDT program 20.37 22.94 –2.57 .508 –.09
Percentage of students that reported they “Probably Will” or “Definitely Will” use the following within the next year
Any substance 33.58 32.81 .77 .937 .02
Any substance except alcohol and tobacco 12.21 11.89 .32 .986 .02
Mean perceived positive consequences of substance 
use scalec
2.01 2.01 .00 .998 .00
Mean perceived negative consequences of substance 
use scaled
4.02 3.95 .07 .304 .07
Mean school connectedness scalee 2.80 2.80 .01 .902 .01
Sample size 1 350f 930f
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TABLE 1 (continued)
Impacts of MRSDT on non-participants in covered-activity
Conclusions of the 
authors
MRSDT shows promise in reducing illicit substance use among high school students. The impacts of this study were measured 
for a one-year period and may not represent longer term effects.
Author (year) Terry-McElrath et al. (2013)
Objective To examine associations between school SDT, substance use and participation in extracurricular activities.
Study design Descriptive analyses: analysis of use questionnaire data collected from 1998 to 2011.
Participants 89 575 students in 883 middle schools and 157 400 students in 1 463 high schools. 
Outcomes Current prevalence of SDT; SDT trends over time; associations between substance use and SDT type, volume or duration among 
the general student population or students participating in activities subject to testing; associations between students’ beliefs/






Percentage of students that reported using the following in the past 6 months
Any substance 49.96 54.91 –4.95 .255 –.12
Any substance except alcohol and tobacco 16.83 19.31 –2.48 .673 –.10
Any substance tested by the district’s MRSDT program 26.88 32.16 –5.28 .146 –.15
Percentage of students that reported using the following in the past 30 days
Any substance 32.74 38.50 –5.75 .126 –.15
Any substance except alcohol and tobacco 10.16 12.69 –2.53 .531 –.15
Any substance tested by the district’s MRSDT program 16.47 21.92 –5.46 .045* –.21
Percentage of students that reported they “Probably Will” or “Definitely Will” use the following within the next year
Any substance 34.09 33.31 .77 .960 .02
Any substance except alcohol and tobacco 8.01 7.93 .08 .999 .01
Mean perceived positive consequences of substance 
use scalec
2.11 2.03 .08 .467 .08
Mean perceived negative consequences of substance 
use scaled
4.09 4.06 .03 .823 .03
Mean school connectedness scalee 2.91 2.91 .01 .862 .01
Sample size 1 350f 1 100f
For both:
a The p-values reported in this table account for the clustering of students within schools and for multiple hypothesis 
testing.
b For dichotomous outcomes, the effect size is calculated using the Cox index, which equals the standardised log odds 
ratio between the treatment and control groups.
c Scale ranges from 1 to 5. Higher values on the scale indicate more positive attitudes towards substance use.
d Scale ranges from 1 to 5. Higher values on the scale indicate more negative attitudes towards substance use.
e Scale ranges from 1 to 4. Higher values on the scale indicate greater connection to school.
f Reported student sample sizes are rounded to the nearest 10 in accordance with the National Center for Education 
Statistics (NCES) publication policy.
* p < 0.05.
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TABLE 1 (continued)
Results Multivariate associations between school drug testing and student past 30-day illicit substance use
Conclusions of the 
authors
Moderately lower marijuana use was associated with any random testing of the general high school student population and 
for school SDT of middle and high school subpopulations specifically subject to testing (athletes or participants in non-athletic 
extracurricular activities). However, SDT was generally associated with increased use of illicit drugs OTM. Because the study 
design is observational and the data are cross-sectional, no strong causal conclusions can be drawn. However, there is evidence 
of lower marijuana use in the presence of SDT, and evidence of higher use of illicit drugs OTM. Until further research can clarify 
these apparently opposing associations, schools should approach SDT with caution.
School Students Use frequency Any/none use




Any testing 883 87 815 –.053 (.065) .97 (.834  1.132)
Any for-cause testing 883 87 815 –.021 (.082) .98 (.828 1.162)
Any random testing 882 87 798 .008 (.111) 1.00 (.797 1.266)
OTM use
Any testing 883 88 827 .012 (.008) 1.03 (.893 1.195)
Any for-cause testing 883 88 827 .009 (.010) 1.00 (.838 1.186)
Any random testing 882 88 810 .017 (.015) 1.10 (.898  1.343)
Student athletes
Marijuana use
Any athlete testing 812 19 861 –.272 (.081) ** .77 (.527  1.131)
Any random athlete testing 512 13 067 –.243 (.085) ** .71 (.464  1.078)
OTM use
Any athlete testing 812 20 050 –.004 (.010) 1.11 (.781  1.584)
Any random athlete testing 512 13 183 .001 (.012) 1.18 (.780  1.781)
Students participating in nonathletic extracurricular activities
Marijuana use
Any nonathlete extracurricular testing 814 21 616 .129 (.176) 1.10 (.727  1.662)
Any random nonathlete extracurricular testing 512 13 840 .016 (.125) .94 (.636  1.379)
OTM use
Any nonathlete extracurricular testing 814 21 776 .045 (.045) 1.50 (.869  2.579)




Any testing 1 463 154 337 .062 (.084) 1.03 (.965  1.104)
Any for-cause testing 1 462 154 198 .182 (.092) * 1.08 (1.006  1.165) *
Volume of for-cause testinga 279 32 585 –.006 (.003) * 1.00 (.997  1.001)
Any random testing 1 461 154 105 –.253 (.102) * .85 (.772  .940) **
Volume of random testinga 114 12 913 –.001 (.001) 1.00 (.999  1.000) +
Random testing among all students 1 460 153 966 –.323 (.190) + .77 (.597  1.003) +
When any random testing was implementeda
This or last year 105 11 325 .209 (.259) 1.03 (.790  1.346)
2–3 years ago –.318 (.212) .95 (.777  1.162)
4+ years ago (ref.) (ref.)
OTM use
Any testing 1 463 156 583 .015 (.006) * 1.10 (1.025  1.184) **
Any for-cause testing 1 462 156 440 .013 (.007) + 1.11 (1.024  1.196) *
Volume of for-cause testing 279 33 016 .000 (.000) 1.00 (.997  1.003)
Any random testing 1 461 156 346 .027 (.011) * 1.11 (1.002  1.220) *
Volume of random testing 114 13 103 .000 (.000) 1.00 (.999  1.000)
Random testing among all students 1 460 156 203 .027 (.023) 1.20 (1.008  1.440) *
When any random testing was implemented
This or last year 105 11 501 .086 (.036) * 1.22 (.937  1.588)
2–3 years ago –.032 (.024) .87 (.720  1.053)
4+ years ago (ref.) (ref.)
Student athletes
Marijuana use
Any athlete testing 1 341 29 252 –.328 (.137) * .80 (.689  .935) **
Any random athlete testing 831 19 536 –.420 (.169) * .76 (.631  .924) **
OTM use
Any athlete testing 1 341 29 609 .004 (.014) 1.21 (.998  1.474) +
Any random athlete testing 831 19 777 –.001 (.017) 1.19 (.916  1.534)
Students participating in nonathletic extracurricular activities
Marijuana use
Any nonathlete extracurricular testing 1 346 34 170 –.135 (.189) .78 (.668  .909) **
Any random nonathlete extracurricular testing 832 22 368 –.308 (.206) .71 (.591  .848) ***
OTM use
Any nonathlete extracurricular testing 1 346 34 527 .039 (.020) * 1.24 (.987  1.547) +
Any random nonathlete extracurricular testing 832 22 610 .010 (.017) 1.07 (.810  1.415)
CI, confidence interval; Coeff, estimated regression coefficient; high school, 10th and 12th grades combined; middle school, 8th grade; OR, 
odds ratio; SE, standard error.  
a Only for students in schools with any of the type of testing specified.  
+ p < 0.10, * p < 0.05, ** p < 0.01, *** p < 0.001.
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TABLE 1 (continued)
Author (year) Yamaguchi et al. (2003)
Objective To examine the association between drug testing and reported drug use by students.
Study design Report. Data for the analyses were obtained through two related studies. Student data were obtained from the Monitoring the 
Future study, supported by the National Institute on Drug Abuse, consisting of nationally representative students in grades 8, 10 
and 12. Data on school characteristics, including drug-testing policies, were obtained from administrators (usually principals) of 
the relevant Monitoring the Future schools under a separately funded research project.
Participants 30 000 8th-grade students in 260 middle schools; 23 000 10th-grade students in 227 high schools; and 23 000 12th-grade 
students in 235 high schools.
Outcomes Student marijuana use, student illicit drug use OTM.
 Results Marijuana use
Conclusions of the 
authors
Does drug testing prevent or inhibit student drug use? Members of the US Supreme Court appear to believe it does. However, 
among the 8th-,10th- and 12th-grade students surveyed in this study, school drug testing was not associated with either the 
prevalence or the frequency of student marijuana use or of other illicit drug use. Nor was drug testing of athletes associated 
with lower-than-average marijuana and other illicit drug use by high school male athletes. Even among those who identified 
themselves as fairly experienced marijuana users, drug testing was also not associated with either the prevalence or the 
frequency of marijuana or other illicit drug use.
12-month marijuana use 12-month other than marijuana use
1–7 Scale Prevalence 1–7 Scale Prevalence
N Mean SD Mean SD N Mean SD Mean SD
8th grade all students
Drug testing of any kind
Yes 26 423 1.41 1.14 .16 .35 26 877 1.05 .22 .10 .29
No 3 236 1.40 1.16 .15 .35 3 279 1.05 .28 .10 .30
Drug testing based on cause/suspicion
Yes 27 024 1.41 1.15 .16 .35 27 486 1.05 .23 .10 .29
No 2 616 1.36 1.04 .14 .32 2 650 1.04 .23 .09 ‘27
10th grade all students
Drug testing of any kind
Yes 17 858 2.01 1.81 .31 .46 18 066 1.10 .35 .17 .37
No 5 559 2.01 1.80 .33 .47 5.629 1.09 .33 .16 .37
Drug testing based on cause/suspicion
Yes 18 915 2.01 1.82 .32 .46 19 135 1.10 .35 .17 .37
No 4 502 1.99 1.73 .32 .46 4 560 1.09 .31 .16 .35
12th grade all students
Drug testing of any kind
Yes 17 437 2.20 1.94 .36 .47 17 758 1.12 .41 .19 .39
No 5 653 2.27 1.97 .37 .47 5 740 1.14 .43 .21 .39
Drug testing based on cause/suspicion
Yes 18 584 2.19 1.93 .36 .47 18 923 1.12 .41 .19 .39
No 4 506 2.34 1.98 .39 .47 4 575 1.15 .44 .21 .39
Note: Weights were used to estimate a nationally representative sample of students in schools.
Drug testing and other illicit drug use
Similar to results for marijuana use, drug testing of any kind and drug testing for cause and suspicion were not significant 
predictors of the use of other illicit drugs among students in grades 8, 10, and 12. Even after controlling for student 
demographic characteristics, drug testing was not a significant predictor of other illicit drug use in any of the samples.
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TABLE A1
Characteristics of the excluded studies
Author Description of study
Coombs and Ryan (1990) To evaluate to what extent drug testing effectively identifies drug users and prevents 
further drug use among the 624 intercollegiate athletes (500 drug-tested and 124 not-
tested participants)
Coombs and Coombs (1991) To assess the impact of drug testing on the morale and well-being of mandatory 
participants
DuPont et al. (2013) The paper describes the goals and current practice of school-based RSDT as part of an 
overall drug prevention strategy, briefly explores the available literature evaluating its 
effectiveness and discusses the controversies related to RSDT
Garcia-Jimenez et al. (2008) To determine the current or past use of drug abuse through a questionnaire applied to a 
student population at the Universidad Autnoma del Estado de Morelos
James-Burdumy et al. (2010) Report of the US National Centre for Education Evaluation and Regional Assistance 
aimed at presenting information on the conditions of implementation and impacts of the 
programmes being evaluated
Levy et al. (2014) The objective of this report was to provide guidance to paediatricians and other clinicians 
on the efficacy and efficient use of drug testing based on a review of the nascent scientific 
literature, policy guidelines and published clinical recommendations
Shek (2010) Review to explore the effectiveness of school drug testing, particularly in Chinese culture, 
including studies already included in this review
Sznitman and Romer (2014) The study, on the basis of telephonic interview, aims to test the relation between two school 
characteristics and drug use
Velasquez (2010) The narrative review provides a review of the literature, as well as a summary of recent 
RSDT events in US public schools without numerical data
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